High drug prices are not justified by industry’s research and development spending, argue experts
High drug prices are not justified by industry’s spending on research and development (R&D), argue experts in The BMJ today. Aris Angelis and colleagues point out that from 1999 to 2018, the…
You must be logged in to post a comment.